The use of transarterial chemoembolization with radiotherapy led to improved survival outcomes for patients with unresectable hepatocellular carcinoma and portal vein tumor thrombus, compared with ...

Portal vein blood flow accounts for 75% of total hepatic blood flow, with the hepatic artery accounting for the remainder. As a result, portal vein occlusion may have significant consequences for ...

Update results from ALTER-H004 study: Anlotinib combined with TACE as adjuvant therapy in hepatocellular carcinoma patients at high risk of recurrence after surgery—A single-arm, multicenter, phase II ...

Portal vein thrombosis means that there is a blood clot in the portal vein. This vein carries blood to the liver. A clot can fully or partially block the portal vein, as well as blood flow to the ...

Background A 52-year-old man presented to hospital having experienced abdominal pain, abdominal distention and oliguria for 1 week. An abdominal CT scan revealed thrombosis in the superior mesenteric ...

A randomized, multicenter controlled study was conducted from January 2016 to December 2017 in patients with resectable HCC and PVTT. Patients were randomly assigned to receive neoadjuvant RT followed ...

Please provide your email address to receive an email when new articles are posted on . Postprocedural imaging showed 10% of patients had new portal vein thrombosis after transarterial ...

Nurses and oncologists need to give portal vein thrombosis a closer look, according to one oncolgy nurse. Despite its deadly potential, portal vein thrombosis (PVT) is a frequently overlooked side ...

f you have deep vein thrombosis, or DVT, it’s key to remove or contain the blood clot in your vein before it breaks loose. Common treatments include blood thinners, internal filters, or “clot busters” ...

The clinical consequences of PVT are varied. [14] Although some patients remain asymptomatic, blockage of portal vein blood flow can produce ischemic hepatitis; worsening portal hypertension; and, ...